Praxis Precision (PRAX) Medicines announced the appointment of Jeffrey Kindler and Stuart Arbuckle to its board of directors, and the promotions of Megan Sniecinski to COO and Dr. Steven Petrou to President of Research & Development.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRAX:
- Praxis Precision Medicines Announces Major Underwritten Equity Offering
- Praxis Precision 2.212M share Spot Secondary priced at $260.00
- Praxis Precision announces common stock and warrants offering, no amount given
- Praxis Precision price target raised to $460 from $315 at Needham
- 3 ‘Strong Buy’ Stocks to Buy Today, 12/31/2025, According to Top Analysts